India to Australia: Meropenem Export Trade Route

The India to Australia Meropenem corridor is one of India's established pharmaceutical export routes, with 38 shipments documented worth a combined $19.4M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 82% of all export value, reflecting the consolidated nature of India's meropenem manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $510.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with meropenem's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 28.7%, placing it at rank #20 among India's top meropenem export destinations globally.

On the import side, key buyers of Indian meropenem in Australia include M/S. SUN PHARMA ANZ PTY LTD, G H, GENERIC HEALTH and 7 others. M/S. SUN PHARMA ANZ PTY LTD is the single largest importer with 4 shipments valued at $15.4M USD.

India's meropenem exports to Australia are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, VENUS REMEDIES LIMITED, VENUS REMEDIES LIMITED — together account for 99% of total trade value on this route. The average shipment value of $510.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as meropenem ranbaxy 500 mg pack:5 vials ba and meropenem 1.0 gm powder for solution for , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, M/S. SUN PHARMA ANZ PTY LTD is the largest importer with 4 shipments worth $15.4M USD — representing 79% of all meropenem imports from India on this route. A total of 10 buyers are active on this corridor.